4.6 Meeting Abstract

Ustekinumab efficiency as a higher-line therapy in association with serum levels in patients with Crohn's disease

Journal

JOURNAL OF CROHNS & COLITIS
Volume 13, Issue -, Pages S438-S439

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ecco-jcc/jjy222.765

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available